Sana Biotechnology SANA Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Sana Biotechnology’s reported figures.
Based on the most recent quarter.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's cash ratio?
- Sana Biotechnology (SANA) reported cash ratio of 1× in Q1 2026.
- How has Sana Biotechnology's cash ratio changed year-over-year?
- Sana Biotechnology's cash ratio decreased by 66.5% year-over-year, from 2.9× to 1×.
- What is the long-term trend for Sana Biotechnology's cash ratio?
- Over 5 years (2020 to 2025), Sana Biotechnology's cash ratio has grown at a -25.5% compound annual growth rate (CAGR), from 4× to 0.9×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.